Systematic review of green tea epigallocatechin gallate in reducing low-density lipoprotein cholesterol levels of humans

International Journal of Food Sciences and Nutrition

Volumn 67, Issue 6, 2016, Pages 606-613

  Momose, Yuko ^a   Maeda Yamamoto, Mari ^a   Nabetani, Hiroshi ^a  

^a NATIONAL FOOD RESEARCH INSTITUTE   (Japan)

Author keywords

Catechin; flavonoid; lipid profile; polyphenol

Indexed keywords

CATECHIN; EPIGALLOCATECHIN GALLATE; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLANT EXTRACT; TEA;

ANALOGS AND DERIVATIVES; BLOOD; BODY MASS; CHEMISTRY; HUMAN; OBESITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); TEA;

BODY MASS INDEX; CATECHIN; CHOLESTEROL, LDL; HUMANS; OBESITY; PLANT EXTRACTS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TEA;

EID: 84975260999     PISSN: 09637486     EISSN: 14653478     Source Type: Journal    
DOI: 10.1080/09637486.2016.1196655     Document Type: Article

References (30)

1. A.Alpérovitch, T.Kurth, M.Bertrand, M.L.Ancelin, C.Helmer, S.Debette, C.Tzourio 2015. Primary prevention with lipid lowering drugs and long term risk of vascular events in older people: population based cohort study. BMJ. 350:h2335.
2. A.Basu, K.Sanchez, M.J.Leyva, M.Wu, N.M.Betts, C.E.Aston, T.J.Lyons 2010. Green tea supplementation affects body weight, lipids, and lipid peroxidation in obese subjects with metabolic syndrome. J Am Coll Nutr. 29:31–40.
3. A.L.Brown, J.Lane, C.Holyoak, B.Nicol, A.E.Mayes, T.Dadd 2011. Health effects of green tea catechins in overweight and obese men: a randomised controlled cross-over trial. Br J Nutr. 106:1880–1889.
4. I.J.Chen, C.Y.Liu, J.P.Chiu, C.H.Hsu 2016. Therapeutic effect of high-dose green tea extract on weight reduction: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. 35:592–599.
5. K.Diepvens, E.M.Kovacs, N.Vogels, M.S.Westerterp-Plantenga 2006. Metabolic effects of green tea and of phases of weight loss. Physiol Behav. 87:185–191.
6. M.J.Domanski, V.Fuster, F.Diaz-Mitoma, S.Grundy, D.Lloyd-Jones, M.Mamdani, R.Roberts, K.Thorpe, J.Hall, J.A.Udell,. 2015. Next steps in primary prevention of coronary heart disease: rationale for and design of the ECAD trial. J Am Coll Cardiol. 66:1828–1836.
7. D.Erba, P.Riso, A.Bordoni, P.Foti, P.L.Biagi, G.Testolin 2005. Effectiveness of moderate green tea consumption on antioxidative status and plasma lipid profile in humans. J Nutr. 139:58–62.
8. J.Higgins, S.Green [Internet]. 2011. Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0. The Cochrane Collaboration, Medical Research Council. [Online]; [cited 2015 Sept 9]. Available from: http://handbook.cochrane.org
9. C.H.Hsu, T.H.Tsai, Y.H.Kao, K.C.Hwang, T.Y.Tseng, P.Chou 2008. Effect of green tea extract on obese women: a randomized, double-blind, placebo-controlled clinical trial. Clin Nutr. 27:363–370.
10. A.R.Jadad, R.A.Moore, D.Carroll, C.Jenkinson, D.J.Reynolds, D.J.Gavaghan, H.J.McQuay 1996. Assessing the quality of reports of randomized clinical trials: is blinding necessary? Control Clin Trials. 17:1–12.
11. O.Kajimoto, Y.Kajimoto, M.Takeda, A.Nozasa, Y.Suzuki, T.Kakuda 2006. Reduction of LDL cholesterol in women by long-term ingestion of tea catechin beverages with a galloyl moiety. Health Sci. 22:60–71.
12. O.Kajimoto, Y.Kajimoto, M.Yabune, A.Nozasa, K.Nagata, T.Kakuda 2003. Tea catechins reduce serum cholesterol levels in mild and borderline hypercholesterolemia patients. J Clin Biochem Nutr. 33:101–111.
13. S.Khalesi, J.Sun, N.Buys, A.Jamshidi, E.Nikbakht-Nasrabadi, H.Khosravi-Boroujeni 2014. Green tea catechins and blood pressure: a systematic review and meta-analysis of randomised controlled trials. Eur J Nutr. 53:1299–1311.
14. A.Kim, A.Chiu, M.K.Barone, D.Avino, F.Wang, C.I.Coleman, O.J.Phung 2011. Green tea catechins decrease total and low-density lipoprotein cholesterol: a systematic review and meta-analysis. J Am Diet Assoc. 111:1720–1729.
15. S.Kuriyama, T.Shimazu, K.Ohmori, N.Kikuchi, N.Nakaya, Y.Nishino, Y.Tsubono, I.Tsuji 2006. Green tea consumption and mortality due to cardiovascular disease, cancer, and all causes in Japan: the Ohsaki study. JAMA. 296:1255–1265.
16. K.C.Maki, M.S.Reeves, M.Farmer, K.Yasunaga, N.Matsuo, Y.Katsuragi, M.Komikado, I.Tokimitsu, D.Wilder, F.Jones,. 2009. Green tea catechin consumption enhances exercise-induced abdominal fat loss in overweight and obese adults. J Nutr. 139:264–270.
17. R.Miyazaki, K.Kotani, M.Ayabe, K.Tsuzaki, J.Shimada, N.Sakane, H.Takase, H.Ichikawa, Y.Yonei, K.Ishii. 2013. Minor effects of green tea catechin supplementation on cardiovascular risk markers in active older people: a randomized controlled trial. Geriatr Gerontol Int. 13:622–629.
18. D.Moher, L.Shamseer, M.Clarke, D.Ghersi, A.Liberati, M.Petticrew, P.Shekelle, L.A.Stewart, PRISMA-P Group. 2015. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Syst Rev. 4:1.
19. T.Nagao, Y.Komine, S.Soga, S.Meguro, T.Hase, Y.Tanaka, I.Tokimitsu 2005. Ingestion of a tea rich in catechins leads to a reduction in body fat and malondialdehyde-modified LDL in men. Am J Clin Nutr. 81:122–129.
20. T.Nagao, T.Hase, I.Tokimitsu 2007. A green tea extract high in catechins reduces body fat and cardiovascular risks in humans. Obesity (Silver Spring). 15:1473–1483.
21. M.P.Nantz, C.A.Rowe, J.F.Bukowski, S.S.Percival 2009. Standardized capsule of Camellia sinensis lowers cardiovascular risk factors in a randomized, double-blind, placebo-controlled study. Nutrition. 25:147–154.
22. A.Nozawa, A.Sugimoto, T.Kadota, K.Nagata, T.Horiguchi 2002. Effect of lowering serum cholesterol of the tea catechin beverage. J Nutr Food. 5:1–9.
23. I.Onakpoya, E.Spencer, C.Heneghan, M.Thompson 2014. The effect of green tea on blood pressure and lipid profile: a systematic review and meta-analysis of randomized clinical trials. Nutr Metab Cardiovasc Dis. 24:823–836.
24. E.Saito, M.Inoue, N.Sawada, T.Shimazu, T.Yamaji, M.Iwasaki, S.Sasazuki, M.Noda, H.Iso, S.Tsugane, JPHC Study Group. 2015. Association of green tea consumption with mortality due to all causes and major causes of death in a Japanese population: the Japan public health center-based prospective study (JPHC Study). Ann Epidemiol. 25:512–518.
25. J.Suliburska, P.Bogdanski, M.Szulinska, M.Stepien, D.Pupek-Musialik, A.Jablecka 2012. Effects of green tea supplementation on elements, total antioxidants, lipids, and glucose values in the serum of obese patients. Biol Trace Elem Res. 149:315–322.
26. Y.Suzuki, A.Nozasa, T.Umino, Y.Sagesaka, R.Kadota, O.Kajimoto, K.Nagata,. 2005. Safety evaluation of excessive intake of the tea catechin beverage. J Nutr Food. 8:1–12.
27. E.Suzuki, T.Yorifuji, S.Takao, H.Komatsu, M.Sugiyama, T.Ohta, K.Ishikawa-Takata, H.Doi 2009. Green tea consumption and mortality among Japanese elderly people: the prospective Shizuoka elderly cohort. Ann Epidemiol. 19:732–739.
28. M.Takeshita, S.Takashima, U.Harada, E.Shibata, N.Hosoya, H.Takase, K.Otsuka, S.Meguro, M.Komikado, I.Tokimitsu. 2008. Effects of long-term consumption of tea catechins-enriched beverage with no caffeine on body composition in humans. Jpn Pharmacol Ther. 36:767–776.
29. K.H.van Het Hof, H.S.de Boer, S.A.Wiseman, N.Lien, J.A.Westrate, L.B.Tijburg 1997. Consumption of green or black tea does not increase resistance of low-density lipoprotein to oxidation in humans. Am J Clin Nutr. 66:1125–1132.
30. X.X.Zheng, Y.L.Xu, S.H.Li, X.X.Liu, R.Hui, X.H.Huang 2011. Green tea intake lowers fasting serum total and LDL cholesterol in adults: a meta-analysis of 14 randomized controlled trials. Am J Clin Nutr. 94:601–610.